Last quarter (Q0 0), Algernon Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Algernon Pharmaceuticals's net income was $-421.43K. See Algernon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Aug 24	Aug 23	Aug 22	Aug 21	Aug 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 2.41M	$ 2.41M	$ 5.24M	$ 6.02M	$ 8.05M	$ 8.66M
Operating Income	$ -2.41M	$ -2.41M	$ -5.24M	$ -6.02M	$ -8.05M	$ -8.66M
Net Non Operating Interest Income Expense	$ 1.37K	$ 1.37K	$ 2.10K	$ 2.08K	$ -11.93K	$ -35.08K
Other Income Expense	$ -1.91M	$ -1.91M	$ 1.54M	$ -36.48K	$ 305.12K	$ 87.77K
Pretax Income	$ -502.98K	$ -502.98K	$ -6.78M	$ -6.05M	$ -7.73M	$ -8.54M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -502.98K	$ -502.98K	$ -6.78M	$ -6.05M	$ -7.73M	$ -8.54M
Basic EPS	$ -0.01	$ 0.03	$ 0.45	$ 0.87	$ -1.24	$ -2.50
Diluted EPS	-	$ 0.03	$ 0.45	$ 0.87	$ -1.24	$ -2.50
Basic Average Shares	$ 80.19M	$ 20.05M	$ 15.15M	$ 6.95M	$ 6.23M	$ 3.52M
Diluted Average Shares	$ 80.19M	$ 20.05M	$ 15.15M	$ 6.95M	$ 6.23M	$ 3.52M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 885.86K	$ 2.41M	$ 5.24M	$ 6.02M	$ -8.05M	$ -8.66M
Net Income From Continuing And Discontinued Operation	$ -502.98K	$ -502.98K	$ -6.78M	$ -6.05M	$ -7.73M	$ -8.54M
Normalized Income	$ -2.16M	$ -2.16M	$ -3.44M	$ -4.41M	$ -5.68M	$ -6.36M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -502.98K	$ -502.98K	$ -6.78M	$ -6.05M	$ -7.73M	$ -8.54M
EBITDA	$ -484.06K	$ -476.42K	$ -6.73M	$ -6.02M	$ -7.73M	$ -8.54M

Currency in USD

Algernon Pharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing